Pagrindinis4568 • TYO
add
Daiichi Sankyo Co Ltd
Ankstesnė uždarymo kaina
3 220,00 ¥
Dienos intervalas
3 161,00 ¥ - 3 215,00 ¥
Metų intervalas
3 036,00 ¥ - 4 564,00 ¥
Bendroji vertė rinkoje
6,03 trln. JPY
Vidutinė prekybos apimtis
6,94 mln.
Kainos ir pajamų santykis
21,26
Pajamos iš dividendų
2,17 %
Pagrindinė akcijų birža
TYO
Rinkos naujienos
Apie
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Generalinis direktorius
Įkurta
1899
Pagrindinė būstinė
Svetainė
Darbuotojų skaičius
19 765